Skip to content

Prospective study for improving the quality of pathological sections by pulling and twisting biopsy

Prospective study for improving the quality of pathological sections by pulling and twisting biopsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023053
Enrollment
Unknown
Registered
2019-05-09
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biopsy method and pathological section quality

Interventions

pulling and twisting biopsy:To perform a biopsy using a pulling and twisting biopsy.
Traditional biopsy:Biopsy in the traditional way
water injection compression group:Hemostasis of bleeding after biopsy by the pressure of water column
Spraying norepinephrine ice brine group:Hemostasis of bleeding after biopsy by spraying norepinephrine iced saline

Sponsors

Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. aged 20 to 60 years; 2. patients undergoing gastroscopy due to physical examination or other discomfort; 3. patients undergoing endoscopic biopsy for barrett esophagus, intestinal metaplasia, atrophy, suspected gastroesophageal early cancer, and HP infection.

Exclusion criteria

Exclusion criteria: 1. severe heart disease: such as severe heart rhythm disorder, myocardial infarction active period, severe heart failure; 2. severe lung disease; asthma, respiratory failure can not be supine; 3. people with mental disorders or disturbances of consciousness are obviously unable to cooperate; 4. acute phase of esophagus, stomach, duodenal perforation; 5. peptic ulcer active period; 6. acute severe throat disease endoscopy can not be inserted; 7. acute phase of corrosive esophageal injury; 8. esophageal varices; 9. gastroduodenal outflow obstruction accompanied by retention of contents; 10. have a tendency to severe bleeding, or are taking anticoagulants such as aspirin, warfarin, or those with coagulopathy; 11. blood pressure or blood sugar is too high; 12. previous history of chronic hepatitis or cirrhosis or portal hypertension; 13. allergic purpura; 14. gastroscopic performance is suspicious for advanced gastroesophageal cancer; 15. there are other parts (outside the stomach and esophagus) malignant tumors; 16. reluctant to sign informed consent and refuse to participate in the survey; 17. other endoscopic physicians believe that it is not suitable for gastroscopy or endoscopic biopsy.

Design outcomes

Primary

MeasureTime frame
Whether the depth of pathological section reaches the mucosal muscle layer;Biopsy tissue size;Tissue stretching or curling;Extension of pathological sections;Continuity of pathological sections;

Secondary

MeasureTime frame
inadequate hemostasis affects secondary biopsy;

Countries

China

Contacts

Public ContactMuhan Lv

Affiliated Hospital of Southwest Medical University

lvmuhan@swmu.edu.cn+86 15283099635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026